NOVA NEO™ Intracranial Drug-eluting Stent System

A drug-eluting stent designed for intracranial arterial stenosis treatment. The stent is delivered to the narrowed intracranial vessel segment where it provides mechanical scaffolding to maintain vessel patency while releasing therapeutic agents to prevent restenosis and improve outcomes in cerebrovascular disease.

Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.

Polymer-free sirolimus-eluting coronary stent designed for percutaneous coronary intervention (PCI) in patients with coronary artery disease. The Nano+ system delivers sirolimus to inhibit neointimal proliferation while eliminating polymer-related inflammation, reducing restenosis risk. Indicated for coronary artery lesions requiring revascularization with improved biocompatibility.

Specialized stents for treatment of intracranial vascular stenosis and aneurysms. Designed for the unique anatomical and hemodynamic requirements of cerebral vasculature.

Drug-eluting stent for cerebrovascular applications. Used to treat narrowed or blocked cerebral blood vessels.

A new-generation self-expanding nickel-titanium superelastic alloy stent designed for peripheral vascular intervention. The stent features a helical structure design with high flexibility and anti-fracture properties, closed-loop end design for accurate release and positioning, and a thin-walled, low coefficient of friction design for long peripheral artery stents. The delivery system includes an easy-to-operate release handle with stable stent deployment.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.

A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.

Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.